Aroa Biosurgery in trading halt for capital raise

Aroa Biosurgery in trading halt for capital raise
Aroa has five products approved for sale in the US. (Image: Supplied)
Rebecca Stevenson
New Zealand headquartered medical company Aroa will raise capital to boost its presence in the US.The Australian Financial Review reported the company was seeking A$52 million to fund the expansion of its US sales team, as well as research and development.In a June market update, the soft-tissue regeneration company said US medical procedure numbers continued to reflect a positive trend “supporting improved sales momentum”.Aroa has commercial operations based in San Diego and sales professionals across the US. In its 2021 results fo...

More Markets

ANZ heads to court as select committee splits active litigation
Finance

ANZ heads to court as select committee splits active litigation

ANZ NZ consumer-finance case rumbles on as $300m settlement still on offer.

NZ sharemarket up 0.4% despite inflation report
Markets Market Close

NZ sharemarket up 0.4% despite inflation report

The S&P/NZX 50 Index closed at 13,344.96, up 55.75 points or 0.42%.

Graham Skellern 20 Oct 2025
What Infratil likes about Contact Energy
Infrastructure

What Infratil likes about Contact Energy

Infratil is keeping its options open, while TECT diversifies.

Disclosure breaches Class action against ANZ NZ continues
Finance

Disclosure breaches Class action against ANZ NZ continues

It comes as retrospective law tweaks fail to give relief.

Andy Macdonald 20 Oct 2025